Literature DB >> 27620316

Metabolic interactions with cancer epigenetics.

Xia Gao1, Michael A Reid2, Mei Kong2, Jason W Locasale3.   

Abstract

Cancer cells have epigenetic alterations that are known to drive cancer progression. The reversibility of the epigenetic posttranslational modifications on chromatin and DNA renders targeting these modifications an attractive means for cancer therapy. Cellular epigenetic status interacts with cell metabolism, and we are now beginning to understand the nature of how this interaction occurs and the biological contexts that mediate its function. Given the tremendous interest in understanding and targeting metabolic reprogramming in cancer, this nexus also provides opportunities for exploring the liabilities of cancers. This review summarizes recent developments in our understanding of the interaction of cancer metabolism and epigenetics.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acetyl-CoA; Methionine; One-carbon metabolism; S-Adenosyl methionine; Serine; α-Ketoglutarate

Mesh:

Substances:

Year:  2016        PMID: 27620316      PMCID: PMC5344790          DOI: 10.1016/j.mam.2016.09.001

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  107 in total

Review 1.  The history of cancer epigenetics.

Authors:  Andrew P Feinberg; Benjamin Tycko
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

Review 2.  Dynamics of histone acetylation in vivo. A function for acetylation turnover?

Authors:  Jakob H Waterborg
Journal:  Biochem Cell Biol       Date:  2002       Impact factor: 3.626

Review 3.  Epigenetic reprogramming in mammals.

Authors:  Hugh D Morgan; Fátima Santos; Kelly Green; Wendy Dean; Wolf Reik
Journal:  Hum Mol Genet       Date:  2005-04-15       Impact factor: 6.150

4.  Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification.

Authors:  Minjia Tan; Hao Luo; Sangkyu Lee; Fulai Jin; Jeong Soo Yang; Emilie Montellier; Thierry Buchou; Zhongyi Cheng; Sophie Rousseaux; Nisha Rajagopal; Zhike Lu; Zhen Ye; Qin Zhu; Joanna Wysocka; Yang Ye; Saadi Khochbin; Bing Ren; Yingming Zhao
Journal:  Cell       Date:  2011-09-16       Impact factor: 41.582

Review 5.  IDH mutations in glioma and acute myeloid leukemia.

Authors:  Lenny Dang; Shengfang Jin; Shinsan M Su
Journal:  Trends Mol Med       Date:  2010-08-05       Impact factor: 11.951

6.  Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor.

Authors:  Tadahiro Shimazu; Matthew D Hirschey; John Newman; Wenjuan He; Kotaro Shirakawa; Natacha Le Moan; Carrie A Grueter; Hyungwook Lim; Laura R Saunders; Robert D Stevens; Christopher B Newgard; Robert V Farese; Rafael de Cabo; Scott Ulrich; Katerina Akassoglou; Eric Verdin
Journal:  Science       Date:  2012-12-06       Impact factor: 47.728

7.  Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation.

Authors:  Joyce V Lee; Alessandro Carrer; Supriya Shah; Nathaniel W Snyder; Shuanzeng Wei; Sriram Venneti; Andrew J Worth; Zuo-Fei Yuan; Hee-Woong Lim; Shichong Liu; Ellen Jackson; Nicole M Aiello; Naomi B Haas; Timothy R Rebbeck; Alexander Judkins; Kyoung-Jae Won; Lewis A Chodosh; Benjamin A Garcia; Ben Z Stanger; Michael D Feldman; Ian A Blair; Kathryn E Wellen
Journal:  Cell Metab       Date:  2014-07-03       Impact factor: 27.287

Review 8.  Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer.

Authors:  Christoph Plass; Stefan M Pfister; Anders M Lindroth; Olga Bogatyrova; Rainer Claus; Peter Lichter
Journal:  Nat Rev Genet       Date:  2013-10-09       Impact factor: 53.242

9.  An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.

Authors:  Dan Rohle; Janeta Popovici-Muller; Nicolaos Palaskas; Sevin Turcan; Christian Grommes; Carl Campos; Jennifer Tsoi; Owen Clark; Barbara Oldrini; Evangelia Komisopoulou; Kaiko Kunii; Alicia Pedraza; Stefanie Schalm; Lee Silverman; Alexandra Miller; Fang Wang; Hua Yang; Yue Chen; Andrew Kernytsky; Marc K Rosenblum; Wei Liu; Scott A Biller; Shinsan M Su; Cameron W Brennan; Timothy A Chan; Thomas G Graeber; Katharine E Yen; Ingo K Mellinghoff
Journal:  Science       Date:  2013-04-04       Impact factor: 47.728

10.  Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress.

Authors:  Zachary T Schug; Barrie Peck; Dylan T Jones; Qifeng Zhang; Shaun Grosskurth; Israt S Alam; Louise M Goodwin; Elizabeth Smethurst; Susan Mason; Karen Blyth; Lynn McGarry; Daniel James; Emma Shanks; Gabriela Kalna; Rebecca E Saunders; Ming Jiang; Michael Howell; Francois Lassailly; May Zaw Thin; Bradley Spencer-Dene; Gordon Stamp; Niels J F van den Broek; Gillian Mackay; Vinay Bulusu; Jurre J Kamphorst; Saverio Tardito; David Strachan; Adrian L Harris; Eric O Aboagye; Susan E Critchlow; Michael J O Wakelam; Almut Schulze; Eyal Gottlieb
Journal:  Cancer Cell       Date:  2015-01-12       Impact factor: 31.743

View more
  17 in total

1.  Should we consider subcellular compartmentalization of metabolites, and if so, how do we measure them?

Authors:  Kathryn E Wellen; Nathaniel W Snyder
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2019-09       Impact factor: 4.294

Review 2.  Spatiotemporal Control of Acetyl-CoA Metabolism in Chromatin Regulation.

Authors:  Sharanya Sivanand; Isabella Viney; Kathryn E Wellen
Journal:  Trends Biochem Sci       Date:  2017-11-23       Impact factor: 13.807

3.  In Silico Prediction of Metabolic Fluxes in Cancer Cells with Altered S-adenosylmethionine Decarboxylase Activity.

Authors:  Olga Dotsenko; Dmytro Shtofel
Journal:  Cell Biochem Biophys       Date:  2020-10-11       Impact factor: 2.194

Review 4.  The impact of cellular metabolism on chromatin dynamics and epigenetics.

Authors:  Michael A Reid; Ziwei Dai; Jason W Locasale
Journal:  Nat Cell Biol       Date:  2017-10-23       Impact factor: 28.824

Review 5.  Methionine metabolism in health and cancer: a nexus of diet and precision medicine.

Authors:  Sydney M Sanderson; Xia Gao; Ziwei Dai; Jason W Locasale
Journal:  Nat Rev Cancer       Date:  2019-09-12       Impact factor: 60.716

6.  The deacylase SIRT5 supports melanoma viability by influencing chromatin dynamics.

Authors:  William Giblin; Lauren Bringman-Rodenbarger; Angela H Guo; Surinder Kumar; Alexander C Monovich; Ahmed M Mostafa; Mary E Skinner; Michelle Azar; Ahmed Sa Mady; Carolina H Chung; Namrata Kadambi; Keith-Allen Melong; Ho-Joon Lee; Li Zhang; Peter Sajjakulnukit; Sophie Trefely; Erika L Varner; Sowmya Iyer; Min Wang; James S Wilmott; H Peter Soyer; Richard A Sturm; Antonia L Pritchard; Aleodor A Andea; Richard A Scolyer; Mitchell S Stark; David A Scott; Douglas R Fullen; Marcus W Bosenberg; Sriram Chandrasekaran; Zaneta Nikolovska-Coleska; Monique E Verhaegen; Nathaniel W Snyder; Miguel N Rivera; Andrei L Osterman; Costas A Lyssiotis; David B Lombard
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

7.  Diabetes and Cancer: The Epidemiological and Metabolic Associations.

Authors:  Cissy Zhang; Anne Le
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update.

Authors:  Pere Llinàs-Arias; Manel Esteller
Journal:  Open Biol       Date:  2017-09       Impact factor: 6.411

Review 9.  The carnitine system and cancer metabolic plasticity.

Authors:  Mariarosa Anna Beatrice Melone; Anna Valentino; Sabrina Margarucci; Umberto Galderisi; Antonio Giordano; Gianfranco Peluso
Journal:  Cell Death Dis       Date:  2018-02-14       Impact factor: 8.469

Review 10.  Metabolic Coordination of Physiological and Pathological Cardiac Remodeling.

Authors:  Andrew A Gibb; Bradford G Hill
Journal:  Circ Res       Date:  2018-06-22       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.